Recall Record

Tamarac, FL, United States

Unipharma, Llc. recalls

3 recalls recorded since 2018, most recently on 23 September 2019. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0

Terminated Class II Drugs

Recall started
23 September 2019
Terminated
23 March 2021
Reason
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0133-2020, D-0132-2020

Terminated Class II Drugs

Recall started
15 July 2019
Terminated
5 June 2020
Reason
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Distribution
Nationwide in the US.
Initiated
Voluntary: Firm initiated
Recall numbers
D-1632-2019, D-1631-2019, D-1633-2019

Terminated Class II Drugs

Recall started
2 May 2019
Terminated
25 November 2020
Reason
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Distribution
Nationwide and Venezuela
Initiated
Voluntary: Firm initiated
Recall numbers
D-1299-2019, D-1306-2019, D-1296-2019, D-1298-2019, D-1305-2019, D-1304-2019, D-1302-2019, D-1300-2019, D-1297-2019, D-1301-2019, D-1303-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.